Greenwich LifeSciences Files 8-K on Shareholder Vote Matters
Ticker: GLSI · Form: 8-K · Filed: Dec 19, 2024 · CIK: 1799788
| Field | Detail |
|---|---|
| Company | Greenwich Lifesciences, Inc. (GLSI) |
| Form Type | 8-K |
| Filed Date | Dec 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, procedural
Related Tickers: GLSI
TL;DR
GLSI filed an 8-K for a shareholder vote - details to follow.
AI Summary
Greenwich LifeSciences, Inc. filed an 8-K on December 19, 2024, to report the submission of matters to a vote of its security holders. The filing does not contain specific details about the matters to be voted on or any financial transactions.
Why It Matters
This filing indicates that Greenwich LifeSciences is preparing for or has held a shareholder meeting where important company decisions will be made, requiring investor input.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial information or significant operational changes.
Key Players & Entities
- Greenwich LifeSciences, Inc. (company) — Registrant
- December 19, 2024 (date) — Date of Report
FAQ
What specific matters are being submitted for a vote of security holders?
The filing does not specify the exact matters to be voted on, only that they are being submitted for a vote.
When did the earliest event reported in this filing occur?
The earliest event reported occurred on December 19, 2024.
What is the principal executive office address for Greenwich LifeSciences, Inc.?
The principal executive office is located at 3992 Bluebonnet Dr, Building 14, Stafford, TX 77477.
What is the company's telephone number?
The company's telephone number is (832) 819-3232.
What is the SIC code for Greenwich LifeSciences, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 645 words · 3 min read · ~2 pages · Grade level 11.9 · Accepted 2024-12-19 16:15:22
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value GLSI The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 48KB
- 0001493152-24-050777.txt ( ) — 222KB
- glsi-20241219.xsd (EX-101.SCH) — 3KB
- glsi-20241219_lab.xml (EX-101.LAB) — 33KB
- glsi-20241219_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Greenwich LifeSciences, Inc. Date: December 19, 2024 By: /s/ Snehal Patel Snehal Patel Chief Executive Officer -3-